This suggests that FLOT chemotherapy regimen may both increase the expression of B7-H6 on the tumour cell surface and aid in mediating the shedding of B7-H6 into the tumour microenvironment which may lead to defective NK cell function. Here, NCR3LG1 is linked to neoplasm.